首页> 美国卫生研究院文献>Respiratory Medicine Case Reports >Fluoroquinolone resistant tuberculosis: A case report and literature review
【2h】

Fluoroquinolone resistant tuberculosis: A case report and literature review

机译:氟喹诺酮类耐药结核病:一例报告并文献复习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite the advancements made in medicine and treatment of tuberculosis over the last century, it remains a significant healthcare challenge. It remains the leading cause of death from a single infectious agent and the ninth leading cause of death worldwide. A 23-year-old male with a history of tuberculosis treated in Nepal seven years prior, presented to the emergency department with one week of hemoptysis, fever, chills, night sweats and weight loss. A CT scan of the chest showed multiple cavitary lesions at the superior segment of the left lower lobe. He had persistent massive hemoptysis and required blood transfusions. He underwent bronchial artery embolization followed by lobectomy. He was ultimately diagnosed with fluoroquinolone-resistant tuberculosis, and required a prolonged intensive care unit with transfer to a regional tuberculosis center to successfully complete treatment.
机译:尽管在上个世纪医学和结核病治疗方面取得了进步,但它仍然是一项重大的医疗保健挑战。它仍然是单一传染源致死的主要原因,也是全球第九大致死原因。一名7岁以前在尼泊尔接受治疗的23岁男性,曾有结核病史,被送往急诊科,一周咯血,发烧,发冷,盗汗和体重减轻。胸部CT扫描显示左下叶上段有多个空洞病变。他患有持续性大咯血,需要输血。他接受了支气管动脉栓塞手术,随后进行了肺叶切除术。最终他被诊断出患有氟喹诺酮类耐药性结核病,因此需要长期的重症监护病房,然后转移到区域结核病中心以成功完成治疗。

著录项

代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号